Ligand (LGND) Q4 Earnings & Sales Top, 2021 Guidance Raised
1 minuto de lectura
Ligand Pharmaceuticals Incorporated LGND reported fourth-quarter 2020 adjusted earnings of $1.62 per share, which significantly beat the Zacks Consensus Estimate of $1.07. The company had reported adjusted earnings of 71 cents in the year-ago quarter.Ligand Pharmaceuticals Incorporated LGND reported fourth-quarter 2020 adjusted earnings of $1.62 per share, which significantly beat the Zacks Consensus Estimate of $1.07. The company had reported adjusted earnings of 71 cents in the year-ago quarter.Read MoreStocks,InvestingStocks Feed
Descubre más desde Espacioteca
Suscríbete y recibe las últimas entradas en tu correo electrónico.
